In the journey to outperform the market, investors delve into the art of stock selection. Choosing the right stocks can be a powerful driver for wealth accumulation.
After finishing at $55.15 in the prior trading day, CVS Health Corp (NYSE: CVS) closed at $55.90, up 1.36%. In other words, the price has increased by $1.36 from its previous closing price. On the day, 23.61 million shares were traded. CVS stock price reached its highest trading level at $56.43 during the session, while it also had its lowest trading level at $54.96.
Ratios:
Our goal is to gain a better understanding of CVS by taking a closer look at its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 5.34 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 8.62. For the most recent quarter (mrq), Quick Ratio is recorded 0.61 and its Current Ratio is at 0.81. In the meantime, Its Debt-to-Equity ratio is 1.11 whereas as Long-Term Debt/Eq ratio is at 0.99.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, UBS on May 02, 2024, Downgraded its rating to Neutral and sets its target price to $60 from $85 previously.
On May 01, 2024, Leerink Partners Downgraded its rating to Market Perform which previously was Outperform and also lowered its target price recommendation from $87 to $60.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on May 02 ’24 when Mahoney Michael F bought 9,181 shares for $54.49 per share. The transaction valued at 500,294 led to the insider holds 9,356 shares of the business.
LUDWIG EDWARD J bought 1,000 shares of CVS for $53,879 on May 02 ’24. The Director now owns 21,630 shares after completing the transaction at $53.88 per share. On Feb 16 ’24, another insider, Shah Prem S, who serves as the EVP and Pres-Pharm, Consumer W of the company, sold 29,473 shares for $76.95 each. As a result, the insider received 2,267,947 and left with 39,765 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, CVS now has a Market Capitalization of 70175186944 and an Enterprise Value of 139060346880. As of this moment, CVS’s Price-to-Earnings (P/E) ratio for their current fiscal year is 9.82, and their Forward P/E ratio for the next fiscal year is 6.86. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 4.76. For the stock, the TTM Price-to-Sale (P/S) ratio is 0.19 while its Price-to-Book (P/B) ratio in mrq is 0.95. Its current Enterprise Value per Revenue stands at 0.387 whereas that against EBITDA is 8.213.
Stock Price History:
The Beta on a monthly basis for CVS is 0.56, which has changed by -0.2085247 over the last 52 weeks, in comparison to a change of 0.22379243 over the same period for the S&P500. Over the past 52 weeks, CVS has reached a high of $83.25, while it has fallen to a 52-week low of $53.70. The 50-Day Moving Average of the stock is -23.57%, while the 200-Day Moving Average is calculated to be -22.89%.
Shares Statistics:
The stock has traded on average 10.75M shares per day over the past 3-months and 16951380 shares per day over the last 10 days, according to various share statistics. A total of 1.29B shares are outstanding, with a floating share count of 1.25B. Insiders hold about 0.17% of the company’s shares, while institutions hold 82.53% stake in the company. Shares short for CVS as of 1713139200 were 17995667 with a Short Ratio of 1.67, compared to 1710460800 on 18644394. Therefore, it implies a Short% of Shares Outstanding of 17995667 and a Short% of Float of 1.4400001.
Dividends & Splits
In the trailing 12 months, CVS’s forward annual dividend rate was 2.48, compared to 2.54 this year. Against a Trailing Annual Dividend Yield of 0.044968266The stock’s 5-year Average Dividend Yield is 2.86. The current Payout Ratio is 38.34% for CVS, which recently paid a dividend on 2024-04-19 with an ex-dividend date of 1713484800. Stock splits for the company last occurred on 2005-06-07 when the company split stock in a 2:1 ratio.
Earnings Estimates
The current rating of CVS Health Corp (CVS) is the result of assessments by 22.0 analysts actively engaged in evaluating its market dynamics.On average, analysts expect EPS of $1.91 for the current quarter, with a high estimate of $2.31 and a low estimate of $1.64, while EPS last year was $2.21. The consensus estimate for the next quarter is $2.08, with high estimates of $2.41 and low estimates of $1.74.
Analysts are recommending an EPS of between $8.33 and $6.98 for the fiscal current year, implying an average EPS of $7.4. EPS for the following year is $8.22, with 26.0 analysts recommending between $9.53 and $7.52.
Revenue Estimates
18 analysts predict $91.56B in revenue for the current quarter. It ranges from a high estimate of $93.08B to a low estimate of $90.01B. As of the current estimate, CVS Health Corp’s year-ago sales were $88.92BFor the next quarter, 18 analysts are estimating revenue of $92.47B. There is a high estimate of $94.2B for the next quarter, whereas the lowest estimate is $91.22B.
A total of 25 analysts have provided revenue estimates for CVS’s current fiscal year. The highest revenue estimate was $374.08B, while the lowest revenue estimate was $362B, resulting in an average revenue estimate of $369.43B. In the same quarter a year ago, actual revenue was $357.78BBased on 24 analysts’ estimates, the company’s revenue will be $389.24B in the next fiscal year. The high estimate is $408.02B and the low estimate is $376.8B.
